Literature DB >> 16027118

ATRIP oligomerization is required for ATR-dependent checkpoint signaling.

Heather L Ball1, David Cortez.   

Abstract

The ATM and ATR kinases signal cell cycle checkpoint responses to DNA damage. Inactive ATM is an oligomer that is disrupted to form active monomers in response to ionizing radiation. We examined whether ATR is activated by a similar mechanism. We found that the ATRIP subunit of the ATR kinase and ATR itself exist as homooligomers in cells. We did not detect regulation of ATR or ATRIP oligomerization after DNA damage. The predicted coiled-coil domain of ATRIP is essential for ATRIP oligomerization, stable ATR binding, and accumulation of ATRIP at DNA lesions. Additionally, the ATRIP coiled-coil is also required for ATRIP to support ATR-dependent checkpoint signaling to Chk1. Replacing the ATRIP coiled-coil domain with a heterologous dimerization domain restored stable binding to ATR and localization to damage-induced intranuclear foci. Thus, the ATR-ATRIP complex exists in higher order oligomeric states within cells and ATRIP oligomerization is essential for its function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027118      PMCID: PMC1360181          DOI: 10.1074/jbc.M504961200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Cut5 is required for the binding of Atr and DNA polymerase alpha to genotoxin-damaged chromatin.

Authors:  Edgardo R Parrilla-Castellar; Larry M Karnitz
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

2.  Quaternary structure of ATR and effects of ATRIP and replication protein A on its DNA binding and kinase activities.

Authors:  Keziban Unsal-Kaçmaz; Aziz Sancar
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 3.  DNA damage checkpoint and repair centers.

Authors:  Michael Lisby; Rodney Rothstein
Journal:  Curr Opin Cell Biol       Date:  2004-06       Impact factor: 8.382

Review 4.  Initiating cellular stress responses.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

Review 5.  Coiled coils: new structures and new functions.

Authors:  A Lupas
Journal:  Trends Biochem Sci       Date:  1996-10       Impact factor: 13.807

6.  S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe.

Authors:  H D Lindsay; D J Griffiths; R J Edwards; P U Christensen; J M Murray; F Osman; N Walworth; A M Carr
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

7.  A novel protein activity mediates DNA binding of an ATR-ATRIP complex.

Authors:  Ryan D Bomgarden; Dawn Yean; Muh-Ching Yee; Karlene A Cimprich
Journal:  J Biol Chem       Date:  2004-01-14       Impact factor: 5.157

8.  Physical interaction between replication protein A and Rad51 promotes exchange on single-stranded DNA.

Authors:  Melissa E Stauffer; Walter J Chazin
Journal:  J Biol Chem       Date:  2004-03-31       Impact factor: 5.157

9.  ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation.

Authors:  Sharon M Barr; Cindy G Leung; Elbert E Chang; Karlene A Cimprich
Journal:  Curr Biol       Date:  2003-06-17       Impact factor: 10.834

10.  Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control.

Authors:  J A Wright; K S Keegan; D R Herendeen; N J Bentley; A M Carr; M F Hoekstra; P Concannon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  45 in total

1.  TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint.

Authors:  Rachele Cescutti; Simona Negrini; Masaoki Kohzaki; Thanos D Halazonetis
Journal:  EMBO J       Date:  2010-09-24       Impact factor: 11.598

2.  The MORC family: new epigenetic regulators of transcription and DNA damage response.

Authors:  Da-Qiang Li; Sujit S Nair; Rakesh Kumar
Journal:  Epigenetics       Date:  2013-05-17       Impact factor: 4.528

3.  Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation.

Authors:  Shizhou Liu; Simon Bekker-Jensen; Niels Mailand; Claudia Lukas; Jiri Bartek; Jiri Lukas
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

Review 4.  Integrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts.

Authors:  Laura R Barkley; Haruo Ohmori; Cyrus Vaziri
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

Review 5.  DNA damage sensing by the ATM and ATR kinases.

Authors:  Alexandre Maréchal; Lee Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 6.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

7.  Analysis of mutations that dissociate G(2) and essential S phase functions of human ataxia telangiectasia-mutated and Rad3-related (ATR) protein kinase.

Authors:  Edward A Nam; Runxiang Zhao; David Cortez
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

8.  Insights into Rad3 kinase recruitment from the crystal structure of the DNA damage checkpoint protein Rad26.

Authors:  Kasper Røjkjær Andersen
Journal:  J Biol Chem       Date:  2017-03-17       Impact factor: 5.157

9.  Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.

Authors:  Sudhakar Sivasubramaniam; Xuemin Sun; Yen-Ru Pan; Shaohui Wang; Eva Y-H P Lee
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

10.  Functional genomic screens identify CINP as a genome maintenance protein.

Authors:  Courtney A Lovejoy; Xin Xu; Carol E Bansbach; Gloria G Glick; Runxiang Zhao; Fei Ye; Bianca M Sirbu; Laura C Titus; Yu Shyr; David Cortez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.